VoIP-Pal Affirms Court Acceptance of Second Amended Complaint and Service upon Defendants in Federal Antitrust and RICO Lawsuit
Following the effecting timely service and satisfactorily responding to the Court's procedural inquiry, the Honorable Judge Randolph D. Moss issued an order on May 7, 2025, vacating the prior show-cause deadline and discharging the associated order.
Defendants now have until June 22, 2025, to respond to VoIP-Pal's operative complaint, which alleges violations of the RICO statutes, the Sherman and Clayton Antitrust Acts, and Section 251 of the Telecommunications Act of 1996, based on alleged coordinated conduct among Defendants aimed at excluding VoIP-Pal and other potential competitors from the mobile voice-routing market. If RICO violations are proven, liability could extend to all named Defendants involved in the alleged enterprise.
VoIP-Pal will continue to provide updates as the case proceeds through the next phase of litigation.
About VoIP-Pal.com Inc.VoIP-Pal.com, Inc. ('VoIP-Pal') is a publicly traded corporation (OTCQB: VPLM) headquartered in Waco, TX. The company owns a portfolio of patents related to Voice-over-Internet Protocol ('VoIP') technology that it is actively seeking to monetize.
Forward-Looking StatementsThis press release contains forward-looking statements as defined under securities laws. These statements reflect management's current expectations and are inherently uncertain. Litigation outcomes and settlement discussions are unpredictable, and there is no assurance of favorable resolution.
For Further InformationCorporate Website: www.voip-palusa.comIR Inquiries: IR@voip-pal.comIR Contact: Rich Inza, (954) 495-4600
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Clinical Trial Biorepository and Archiving Solutions Market Size Expected to Attain USD 9.69 Billion by 2034
The global clinical trial biorepository and archiving solutions market is valued at USD 4.76 billion in 2025 and is projected to reach approximately USD 9.69 billion by 2034, expanding at a CAGR of 8.21% during the forecast period, according to a study published by Towards Healthcare, a sister company of Precedence Research. Ottawa, Aug. 19, 2025 (GLOBE NEWSWIRE) -- The global clinical trial biorepository and archiving solutions market was valued at USD 4.4 billion in 2024 and is projected to reach approximately USD 9.69 billion by 2034, expanding at a CAGR of 8.21%. The market is fueled by accelerating research and development in different fields of healthcare. The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report @ Key Takeaways North America was dominant in the clinical trial biorepository and archiving solutions market by 49% shares in 2024. Asia Pacific is expected to grow at the fastest CAGR during 2025-2034. By service, the biorepository services segment led the market in 2024. By service, the archiving solution services segment is expected to grow notably in the upcoming years. By product, the clinical products segment dominated the clinical trial biorepository and archiving solutions market in 2024. By product, the preclinical products segment is expected to grow at a notable CAGR in the studied years. By phase, the preclinical segment registered dominance in the market in 2024. By phase, the phase II segment is expected to grow at a rapid CAGR during 2025-2034. Market Overview & Potential Primarily, the clinical trial biorepository and archiving solutions market comprises the secure storage and management of biological samples (like blood, tissue, and DNA) and linked data from clinical trials. Alongside, it has widespread application in various areas, like clinical research, pharmaceutical development, and personalized medicine, with the increasing focus on data integrity and regulatory compliance. Apart from this, expanding data management, optimizing sample storage, and enhancing the use of digital solutions for compliance and collaboration are propelling the overall adoption and expansion of clinical trial biorepository and archiving solutions. What are the Major Growth Drivers Involved in The Growth of The Market? The clinical trial biorepository and archiving solutions market is driven by continuous groundbreakings in biobanking technologies, like automation and data analytics, which are boosting the effectiveness and accuracy of biorepository operations. Along with this, the widespread application of centralized biorepositories and cloud-based archiving solutions possesses greater accessibility, collaboration, and data management is also impacting the overall market development. You can place an order or ask any questions, please feel free to contact us at sales@ What are the Key Trends Associated with the Market? The clinical trial biorepository and archiving solutions market is developing due to the requirement for efficient sample management, regulatory guidelines for data integrity, and the growing demand for personalized medicine and genomic research. In February 2025, Charles River and Deciphex extended their global partnership to progress digital pathology offering with exclusive image management solutions. In January 2025, Moffitt Cancer Center, a leading National Cancer Institute-designated comprehensive cancer center, and Cryoport, Inc., a global company in supply chain solutions for the life sciences industry, collaborated to offer CRYOGENE's state-of-the-art biorepository services to Speros in Pasco County, Florida. What is the Arising Challenge in the Market? In the clinical trial biorepository and archiving solutions market, accelerating expenses for the establishment and maintenance of biorepositories are essential. Moreover, this needs wide-range investments in infrastructure technology, such as temperature-controlled storage, as well as participation of specialized personnel are also creating barriers in the market expansion. Eventually, small-scale and emerging organizations may experience these hurdles in their development. Regional Analysis Become a valued research partner with us - How Did North America Dominate the Market in 2024? In 2024, North America held the biggest revenue share of 49% in the clinical trial biorepository and archiving solutions market. This region fosters an advanced pharmaceutical sector, with numerous clinical trials, and a phenomenal network of biobanks and research institutions. Along with this, major investments in the R&D department by leading players in the US and Canada are boosting the comprehensive development. Apart from this, the US FDA's stricter regulatory landscape enables adequate biorepository solutions for sample and data May 2025, Cybin Inc., a clinical-stage advanced neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, announced its participation in the Alliance Global Partners Healthcare Company Showcase. In January 2025, ONCare Alliance and partnered to develop a multi-omics database and biobank to accelerate biomarker discovery in oncology. What to Expect from Asian Countries in Clinical Trial Biorespository and Archiving Solutions Market? Asia Pacific is anticipated to grow at the fastest CAGR in the clinical trial biorepository and archiving solutions market. Several eminent companies of ASAP countries like China, India, and Japan, resulting in a higher demand for specialized biorepository and archiving solutions. Furthermore, they are supporting the development rigorous clinical trials platform globally. Besides this, ongoing advances in biobanking technologies, especially automated sample handling, cryopreservation techniques, and digital archiving, are optimizing the efficiency and reliability of biorepository solutions. For instance, In June 2025, iNGENū CRO entered into a partnership with Quantum BioPharma to launch a pioneering Australian clinical trial for chronic nociplastic pain in MCAS patients. In February 2025, LabConnect and Australian Clinical Labs' (ACL) Specialised Trials forged a strategic collaboration to boost support of clinical trials in Australia and the Asia-Pacific region. Get the latest insights on healthcare industry segmentation with our Annual Membership: Segmental Insights By Service Analysis Why did the Biorepository Services Segment Lead the Market in 2024? The biorepository services segment held a dominating share of the clinical trial biorepository and archiving solutions market in 2024. Primarily, the segment is propelled by the wider demand for biorepository services in oncology research and customized medicine. Along with this, these services are increasingly merged in the safe and secure storage of biological samples, which are vital for biomarker discovery, treatment response analysis, and targeted therapy development. Whereas, various biorepositories are termed as biosample libraries, providing valuable resources for studies focused on enhancing individual patient care and advancing medical knowledge. Although the archiving solution services segment is predicted to expand at a significant CAGR during 2025-2034. This service plays a prominent role in the maintenance of comprehensive patient records and the facilitation of access to historical medical data, which is necessary for precise diagnoses and efficient healthcare delivery. They also manage a large volume of data during clinical trials, comprising lab results, patient records, and imaging data, ensuring data integrity and accessibility. In the security of significant biological samples and data, these services are acting as a major component in the research findings. By Product Analysis How did the Clinical Products Segment Hold the Largest Share of the Market in 2024? In 2024, the clinical products segment led the clinical trial biorepository and archiving solutions market. This segment mainly encompasses diverse products, such as cryogenic vials, tubes, and other containers designed for long-term preservation of biological samples, as well as barcodes, RFID tags, and software to track samples throughout the trial lifecycle. Additionally, specialized containers and equipment for sample handling are important in early-stage research. Also, these kinds of products provide the maintenance of sample viability, prevention of degradation, and allowance for accurate analysis. However, the preclinical products segment will expand significantly during 2025-2034. Across the globe, various ongoing preclinical studies that need strong sample management for toxicology and genetic analysis fuel the demand for advanced biorepository and archiving systems. As well as preclinical biorepositories, it provides controlled environments, including temperature, humidity, etc., to control the integrity of biological samples, such as tissues, cells, and blood, which are major aspects for accurate analysis and validation. Preclinical products usually consist of different technologies and methodologies for processing and preserving samples, maintaining their quality for downstream analysis. This further expands the drug development process. By Phase Analysis How did the Preclinical Segment Dominate the Market in 2024? In the clinical trial biorepository and archiving solutions market, the preclinical segment captured a major revenue share in 2024. The segment is driven by a rise in R&D spending by numerous biopharmaceutical companies, which is resulting in greater preclinical studies and an enhanced need for trustworthy biorepository and archiving solutions. Nowadays, the preclinical studies are widely employed in the growing development of precision medicine, extensive sample analysis. The phase II segment is anticipated to expand rapidly in the coming years. This phase is related to the study of a drug's efficacy, safety, and potential side effects, which requires meticulous archived and connecting with the corresponding biological samples. During this phase, diverse biological samples, like blood, tissue, and other biospecimens, are collected with the application of biorepositories for their storage. Moreover, the segment is impacted by strict regulatory rules for clinical trials, such as those regarding data integrity and sample preservation, which also propel the need for reliable biorepository and archiving solutions. Browse More Insights of Towards Healthcare: The clinical trial investigative site network market was valued at USD 8.36 billion in 2023 and is projected to reach USD 15.99 billion by 2034, expanding at a CAGR of 6.07% from 2024 to 2034. The global cell and gene therapy clinical trials market stood at USD 10.8 billion in 2024, increased to USD 12.47 billion in 2025, and is expected to climb to USD 45.31 billion by 2034, registering a strong CAGR of 15.43% during 2025–2034. The clinical genomics market was valued at USD 1.06 billion in 2024, grew to USD 1.25 billion in 2025, and is anticipated to reach USD 5.34 billion by 2034, expanding at a CAGR of 17.54% between 2025 and 2034. The preclinical advanced cell models market is witnessing strong momentum and is set to generate substantial revenues, with estimates indicating growth into the hundreds of millions by 2034. The AI in clinical trials for drugs market is also on a robust growth path, projected to achieve significant revenue gains, potentially reaching into the hundreds of millions from 2025 to 2034. The clinical data analytics market was valued at USD 81.65 billion in 2024, rose to USD 104.16 billion in 2025, and is forecasted to surge to USD 930.01 billion by 2034, reflecting an impressive CAGR of 27.57% between 2025 and 2034. The clinical trial design market stood at USD 567.66 million in 2024, grew to USD 613.25 million in 2025, and is projected to reach USD 1,228.57 million by 2034, expanding at a CAGR of 8.04% from 2025 to 2034. The preclinical CRO market was valued at USD 6.8 billion in 2025 and is expected to grow to USD 14.34 billion by 2034, advancing at a CAGR of 8.73% during 2025–2034. The core clinical molecular diagnostics market was estimated at USD 5.3 billion in 2023 and is set to reach USD 14.45 billion by 2034, growing at a CAGR of 9.54% between 2024 and 2034. The decentralized clinical trials (DCTs) market stood at USD 8.29 billion in 2023 and is forecasted to rise to USD 38.2 billion by 2034, with a CAGR of 14.9% from 2024 to 2034. Recent Developments In August 2025, Union Minister Dr. Jitendra Singh launched the country's first Animal Stem Cell Biobank at the National Institute of Animal Biotechnology (NIAB), equipped with 3D bioprinting, advanced cryostorage. In May 2025, Sapio Sciences unveiled an innovative Biorepository Management solution, with accelerated sample management capabilities and platform-wide improvements created to simplify lab operations and support high-throughput research environments. In May 2025, Markel Insurance, the insurance operations within Markel Group Inc., launched its Clinical Trials insurance product to provide best-in-class solutions to assist clinical trials research and product development on an international scale. In April 2025, Axtria Inc., an AI-first data analytics innovator transforming life sciences, introduced LUCCID, short for LLM-based Unstructured Clinical Concept Identification, a novel GenAI-powered solution. In January 2025, Stoke Therapeutics announced alignment with global regulatory agencies and plans to initiate a phase 3 study of Zorevunersen as probably the foremost disease-modifying medicine for the treatment of Dravet syndrome. Clinical Trial Biorepository and Archiving Solutions Market Key Players Medpace American Type Culture Collection (ATCC) Cell&Co BioServices (Cryoport) Brooks Life Sciences (Azenta, Inc.) Patheon (Thermo Fisher Scientific, Inc.) Precision Medicine Group, LLC. Labcorp Drug Development Q2 Solutions LabConnect Charles River Laboratories Segments Covered in The Report By Service Biorepository Services Warehousing & storage Transportation Sample Processing Others Archiving Solution Services Database Indexing and Management Scanning & Destruction By Product Preclinical Products Clinical Products Human Tissue Organs Stem cells Other Biospecimens By Phase Preclinical Phase I Phase II Phase III Phase IV By Region North America U.S. Canada Asia Pacific China Japan India South Korea Thailand Europe Germany UK France Italy Spain Sweden Denmark Norway Latin America Brazil Mexico Argentina Middle East and Africa (MEA) South Africa UAE Saudi Arabia Kuwait To invest in our premium strategic solution and customized market report options, click here: You can place an order or ask any questions, please feel free to contact us at sales@ Access our exclusive, data-rich dashboard dedicated to the healthcare market - built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway. Access the Dashboard: About Us Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research. Dedicated to advancing innovation in the life sciences sector, we build strategic partnerships that generate actionable insights and transformative breakthroughs. As a global strategy consulting firm, we empower life science leaders to gain a competitive edge, drive research excellence, and accelerate sustainable growth. Our Trusted Data Partners Precedence Research | Statifacts | Towards Packaging | Towards Automotive | Towards Food and Beverages | Towards Chemical and Materials | Towards Consumer Goods | Towards Dental | Towards EV Solutions | Nova One Advisor | Healthcare Webwire | Packaging Webwire | Automotive Webwire Find us on social platforms: LinkedIn | Twitter | Instagram | Medium | PinterestError in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 hours ago
- Yahoo
NanoRAM Market by Memory Type, End Use, Industry - Global Forecasts Report 2025-2030
The NanoRAM market offers growth opportunities in advanced memory solutions for data centers, edge computing, and automotive industries. Its energy-efficient, high-performance capabilities support AI and real-time analytics. Collaborative innovation, regional uptake, and strategic supplier diversification are key to addressing adoption challenges. NanoRAM Market Dublin, Aug. 19, 2025 (GLOBE NEWSWIRE) -- The "NanoRAM Market by Memory Type (Ferroelectric Ram, Magnetoresistive Ram, Phase Change Memory), End Use (Client Devices, Data Center, Edge Computing), End User Industry - Global Forecast 2025-2030" report has been added to offering. The NanoRAM market grew from USD 2.96 billion in 2024 to USD 3.19 billion in 2025. It is expected to continue growing at a CAGR of 7.25%, reaching USD 4.51 billion by 2030. The NanoRAM market is experiencing substantial momentum as advanced memory technologies rapidly transform global data storage and computing solutions. Senior decision-makers are closely tracking NanoRAM's evolution, which is fundamentally changing how data is processed, accessed, and retained within next-generation digital infrastructure. Growing demand for high-performance, persistent, and energy-efficient memory is driving NanoRAM adoption in critical sectors including data centers, edge computing platforms, and automotive systems. Market momentum is further supported by accelerated research, expanded production capacities, and partnerships across the semiconductor value chain. Scope & Segmentation The NanoRAM market report provides a comprehensive overview across technologies, applications, and geographies, offering a deep-dive into the factors shaping adoption strategies for executive leaders. Memory Types: Ferroelectric RAM (including Hafnium Oxide and PZT-based variants), Magnetoresistive RAM (Spin Transfer Torque RAM, Toggle RAM), Phase Change Memory (Doped Chalcogenide, Germanium Antimony Telluride), Resistive RAM (Conductive Bridge, Oxide-based architectures). End Uses: Client devices (personal computers, smartphones, wearables), data centers (networking equipment, servers, storage systems), edge computing (industrial IoT, IoT gateways). End User Industries: Automotive (advanced driver assistance systems, infotainment, telematics), consumer electronics (smart TVs, smartphones, tablets), healthcare (diagnostic instruments, medical devices, wearable health monitors), industrial (automation, process control, robotics), telecommunications (base stations, routers, switches). Regions Covered: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan). Key Companies: Nantero, Inc.; Fujitsu Semiconductor Limited; SK hynix Inc.; GlobalFoundries Inc.; Taiwan Semiconductor Manufacturing Company Limited; Macronix International Co., Ltd.; Powerchip Technology Corporation; Texas Instruments Incorporated; International Business Machines Corporation; Kioxia Corporation. NanoRAM Key Takeaways for Decision-Makers The integration of NanoRAM enables persistent storage with near-zero latency and high reliability, meeting emerging needs in AI, machine learning, and real-time analytics. Architectural convergence between memory and logic is reshaping compute and storage design, with NanoRAM positioned at the forefront of this transition. Diverse memory technologies-including ferroelectric, magnetoresistive, phase change, and resistive RAM-allow tailored solutions across industry ecosystems, supporting both high-speed and low-power requirements. Collaboration between foundries, OEMs, and system integrators fosters robust innovation pipelines, accelerating NanoRAM's market readiness and sectoral penetration. Rapid regional uptake is driven by targeted policy incentives, manufacturing investments, and research partnerships, resulting in a complex adoption landscape with nuanced opportunities and challenges. Tariff Impact: Navigating United States Trade Policy Recent tariffs imposed by the United States in 2025 have introduced sourcing complexities and increased input costs for NanoRAM components. Many organizations are adopting strategic supplier diversification, developing tariff-resilient material pathways, and leveraging cross-border collaborations to mitigate potential supply chain disruptions. These actions are vital for sustaining innovation momentum while aligning with evolving policy landscapes. Methodology & Data Sources This report utilizes a hybrid research design. Initial analysis is based on published literature and industry reports, followed by in-depth interviews with executives and technical experts. Rigorous data triangulation and expert validation workshops ensure the accuracy and business relevance of strategic recommendations. Why This Report Matters Provides a clear and actionable framework for evaluating NanoRAM's sectoral relevance and emerging use cases across diverse industries. Equips executives with a holistic perspective on competitive differentiation, technology roadmaps, and collaborative innovation models. Enables effective navigation of regulatory risks and supply chain complexities in a rapidly changing global environment. Conclusion NanoRAM is redefining the landscape of next-generation memory solutions. Early alignment with this technology's trajectory allows organizations to gain performance, reliability, and innovation advantages for future success. Key Attributes: Report Attribute Details No. of Pages 189 Forecast Period 2025 - 2030 Estimated Market Value (USD) in 2025 $3.19 Billion Forecasted Market Value (USD) by 2030 $4.51 Billion Compound Annual Growth Rate 7.2% Regions Covered Global Key Topics Covered: 1. Preface1.1. Objectives of the Study1.2. Market Segmentation & Coverage1.3. Years Considered for the Study1.4. Currency & Pricing1.5. Language1.6. Stakeholders2. Research Methodology2.1. Define: Research Objective2.2. Determine: Research Design2.3. Prepare: Research Instrument2.4. Collect: Data Source2.5. Analyze: Data Interpretation2.6. Formulate: Data Verification2.7. Publish: Research Report2.8. Repeat: Report Update3. Executive Summary4. Market Overview4.1. Introduction4.2. Market Sizing & Forecasting5. Market Dynamics5.1. Expansion of neuromorphic computing applications driving demand for high-density NanoRAM solutions5.2. Integration of NanoRAM in edge AI devices to improve real-time data processing efficiency5.3. Collaboration between semiconductor foundries and material scientists to scale NanoRAM fabrication processes5.4. Adoption of NanoRAM for ultra-low-power IoT sensor networks to extend battery life in remote deployments5.5. Development of three-dimensional stacking techniques for enhancing NanoRAM storage density and performance5.6. Emergence of radiation-hardened NanoRAM variants for space and defense electronics applications5.7. Strategic partnerships between tech giants and startups to accelerate NanoRAM commercialization efforts5.8. Impact of metal-oxide resistive switching innovations on the reliability and endurance of NanoRAM modules5.9. Regulatory and supply chain challenges influencing global NanoRAM component standardization and availability5.10. Growth in automotive electronics using NanoRAM for advanced driver assistance and in-vehicle infotainment systems6. Market Insights6.1. Porter's Five Forces Analysis6.2. PESTLE Analysis7. Cumulative Impact of United States Tariffs 2025 Companies Featured Nantero, Inc. Fujitsu Semiconductor Limited SK hynix Inc. GlobalFoundries Inc. Taiwan Semiconductor Manufacturing Company Limited Macronix International Co., Ltd. Powerchip Technology Corporation Texas Instruments Incorporated International Business Machines Corporation Kioxia Corporation For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment NanoRAM Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 hours ago
- Yahoo
CLEAR to Launch eGate Pilot Program at Select U.S. Airports Ahead of FIFA World Cup 2026
Public-private partnership aims to drive faster, more secure travel at host city airports across the country at no cost to taxpayers NEW YORK, Aug. 19, 2025 (GLOBE NEWSWIRE) -- CLEAR (NYSE: YOU), the secure identity company, today announced the launch of biometric eGates to help modernize America's airports ahead of the FIFA World Cup 2026 games. CLEAR is investing to improve security and the traveler experience at no cost to taxpayers. Automated eGates are designed to provide a scalable, secure solution to expedite the passenger experience and enhance security. The innovation builds on the Transportation Security Administration's (TSA) efforts to modernize and streamline U.S. airport security checkpoints, with a specific focus on enhancing security, hospitality, and the passenger experience. This first of its kind pilot represents an innovative public–private partnership that enables TSA to scale identity verification and streamline airport processing just in time for the World Cup. With more than 20 million international visitors expected to fly to the U.S. for the tournament — and domestic travel surging through U.S. host cities — checkpoint infrastructure will face unprecedented pressure. As part of this strategic partnership, CLEAR is investing to improve security and the traveler experience at no cost to taxpayers. Starting in August 2025, these eGates will debut at Hartsfield-Jackson Atlanta International Airport (ATL), Ronald Reagan National Airport (DCA), and Seattle–Tacoma International Airport (SEA), with CLEAR planning to expand the eGate implementation across its nationwide network of airports in preparation for the World Cup, America's 250th anniversary celebration, and continuing growth in domestic air travel. 'We are proud to help make America's airports great ahead of the World Cup. The U.S. should be leading on security, hospitality, and the travel experience,' said CLEAR CEO Caryn Seidman Becker. 'This partnership with TSA is a powerful example of how public and private sectors can work together to enhance security and improve the aviation ecosystem. CLEAR is investing in this technology at no cost to taxpayers to modernize our checkpoints and ensure America's airports are ready to meet global expectations. CLEAR's secure identity platform will help unlock a better, safer, and more frictionless experience for all travelers.' CLEAR's eGates are designed to conduct real-time biometric verification, matching a traveler's facial image with their identity document and boarding pass. TSA retains complete operational control: triggering gate access, conducting security vetting, and enforcing government security requirements. CLEAR transmits only limited data (live photo, boarding pass, ID photo used for enrollment and identity information)--it has no access to watchlists, cannot override TSA gate decisions, and does not manually open gates. Once identity and clearance are confirmed, passengers proceed directly to physical screening, bypassing the TSA podium while still undergoing all security screening. About CLEARCLEAR's mission is to strengthen security and create frictionless experiences. With over 33 million Members and a growing network of partners across the world, CLEAR's secure identity platform is transforming the way people live, work, and travel. Whether you are traveling, at the stadium, or on your phone, CLEAR connects you to the things that make you, you—making everyday experiences easier, more secure, and friction-free. CLEAR is committed to privacy done right. Members are always in control of their own information, and we never sell Member data. For more information, visit Forward-Looking StatementsThis release may contain statements that constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. This includes, without limitation, statements related to the planned pilot of eGates and related expansion plans. Investors are cautioned that any and such forward-looking statements are not guarantees of future performance or results and involve risks and uncertainties, and that actual results, developments and events may differ materially from those in the forward-looking statements as a result of various factors, including risks associated with the deployment of eGates, their design and performance, and those described in the Company's filings within the Securities and Exchange Commission, including the sections titled "Risk Factors" in our Annual Report on Form 10- K. The Company disclaims any obligation to update any forward-looking statements contained herein. CLEARmedia@ This press release was published by a CLEAR® Verified individual.
